Severe corticoresistant Mooren Ulcers: management with Rituximab and peripheral lamellar graft
Acta Ophthalmologica, 08/17/2012
Clinical Article
Ben Mhamed H et al. – Rituximab, an anti–CD20 monoclonal antibody, has been successfully used off–label for treatment of Severe corticoresistant Mooren's Ulcer.



